Marinus Announces Positive Preliminary Data From Children With CDKL5 Genetic Disorder
23 January 2017
Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today provided a business overview to outline the clinical status of its CNS-selective GABAA modulator, ganaxolone, and an overview of near-term value-creating milestones expected in 2017.
Pharma CEOs in Davos put brave face on Trump presidency
23 January 2017
Leaders of the global pharmaceutical industry, blasted by incoming U.S. President Donald Trump for "getting away with murder" on drug prices, are putting a brave face on the challenges in their biggest market.
23 January 2017
The FDA in the last eight years has nearly doubled the number of annual foreign plant inspections it conducts, with India and China seeing the largest numbers of inspectors. But the agency still has a huge backlog of foreign plants that have never been seen and is struggling to fill foreign office jobs.
U.K.’s path to ‘hard Brexit’ raises worries, cautious optimism
23 January 2017
The UK BioIndustry Association (BIA) has responded with cautious optimism and concerns to the British prime minister’s clearest statement yet on the priorities for Brexit negotiations. Theresa May drew praise for talking up the importance of science and cross-border collaboration to post-Brexit Britain, but is yet to provide clarity on key points including immigration and regulation.
PhRMA to apply big bucks to new theme in 2017 marketing campaign
20 January 2017
Pharma industry group PhRMA is gearing up for a new marketing campaign to replace its current “From Hope to Cures” push, with a new theme and tagline set to debut this month. The multiyear campaign promises spending in the “tens of millions” each year to drum up support for the reputationally challenged pharma industry.
Where the money is, Part Two: The top cities and regions for biotech VC investments
20 January 2017
Make no mistake about it. Despite another big showing for the Bay Area in the roster of VC deals that delivered in 2016, Cambridge/Boston was the clear leader in the US last year, according to the latest tally of 2016 numbers by Thomson Reuters.
FDA proposes studies on deceptive ads to gauge doc and patient perceptiveness
20 January 2017
Can doctors and patients suss out misleading information in drug ads? That’s what the FDA wants to find out. In a proposed pair of studies, the agency will look at healthcare providers' and patients' responses to determine their ability to detect different levels and types of deception.
19 January 2017
The new year is upon us, and it’s a great time to set out on the right foot by incorporating data into decision-making and business strategy. Crunchbase has access to all data around the innovation economy, and we’re illuminating the trends from 2016 – and what to look out for in 2017 in "The Global Innovation Investment Report-2016".
More than half of trial researchers have financial links to biopharma
19 January 2017
When there are financial ties between researchers working on a clinical study and the drug industry, the data from these tests are more likely to be positive, according to a new report in The BMJ, as more than half of principal investigators were found to have been given money by biopharma
Where the money is, 2016 edition: The top 100 VCs investing in biotech, by the numbers
19 January 2017
Using the latest set of numbers on the top 100 VCs operating in the US, you can sketch out all of the big trends at play in the multibillion-dollar game of biotech investing and startups. this is a good place to get started on that exercise.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024